Results 31 to 40 of about 12,417 (199)

Low-Dose vs. Standard-Dose Intravenous Alteplase in Bridging Therapy Among Patients With Acute Ischemic Stroke: Experience From a Stroke Center in Vietnam

open access: yesFrontiers in Neurology, 2021
Background: To date, the role of bridging intravenous thrombolysis before mechanical thrombectomy (MTE) is controversial but still recommended in eligible patients.
Duy Ton Mai   +18 more
doaj   +1 more source

Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand

open access: yesBMJ Open, 2022
Objectives Endovascular therapy (EVT) has proven to be clinically effective in treating large vessel occlusion acute ischaemic stroke (AIS), either alone or in combination with intravenous alteplase.
Yot Teerawattananon   +7 more
doaj   +1 more source

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review

open access: yesInternational Journal of Emergency Medicine, 2022
Introduction Thrombolysis for acute ischemic stroke (AIS) with alteplase is the currently approved therapy for patients who present within 4.5 h of symptom onset and meet criteria.
Neha Potla, Latha Ganti
doaj   +1 more source

Effect of Alteplase Use on Outcomes in Patients With Atrial Fibrillation: Analysis of the Initiation of Anticoagulation After Cardioembolic Stroke Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Intravenous alteplase improves outcome after acute ischemic stroke without a benefit in 90‐day mortality. There are limited data on whether alteplase is associated with reduced mortality in patients with atrial fibrillation (AF)‐related ...
Shadi Yaghi   +30 more
doaj   +1 more source

Abstract 082: Outcomes of Tenecteplase vs Alteplase in Acute Telestroke Care

open access: diamondStroke Vasc Interv Neurol
Hall N   +5 more
europepmc   +2 more sources

Clinical efficacy and safety analysis of argatroban and alteplase treatment regimens for acute cerebral infarction

open access: yesJournal of Neurorestoratology, 2022
ObjectiveThis study compared the clinical efficacy and safety of argatroban and alteplase in the treatment of acute cerebral infarction.MethodsThis study retrospectively analyzed 131 patients admitted for acute cerebral infarction within 48 h of onset ...
Lifang Xu   +8 more
doaj   +1 more source

Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study

open access: yesMedicina, 2022
Background and Objectives: The study aimed to investigate the efficacy of intravenous thrombolysis with Tenecteplase before thrombectomy for acute ischemic stroke (AIS) patients compared with previous results using Alteplase.
Agnete Teivane   +6 more
doaj   +1 more source

Transcranial Histotripsy Clot and Tissue Ablation for Intracerebral Hemorrhage Evacuation and Other Brain Applications

open access: yes, 2023
STROKE: Vascular and Interventional Neurology, EarlyView.
Jonathan Sukovich   +2 more
wiley   +1 more source

Outcomes of Endovascular Thrombectomy with and without Thrombolysis for Acute Large Artery Ischaemic Stroke at a Tertiary Stroke Centre

open access: yesCerebrovascular Diseases Extra, 2017
Background and Purpose: Endovascular thrombectomy (EVT) improves the functional outcome when added to best medical therapy, including alteplase, in patients with acute ischaemic stroke secondary to large vessel occlusion (LVO) in the anterior circulation.
Chee-Keong Wee   +7 more
doaj   +1 more source

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke

open access: yesNeurology and Therapy, 2023
Introduction This study aimed to investigate the long-term prognostic effects of different alteplase doses on patients with acute ischemic stroke (AIS). Methods In this cohort study, we enrolled 501 patients with AIS treated with intravenous thrombolysis
Mingfeng Zhai   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy